Ab­b­Vie pours $223M in­to build­ing out its bi­o­log­ics ca­pac­i­ty in Sin­ga­pore

Ab­b­Vie is not on­ly build­ing out its pipeline, but al­so its man­u­fac­tur­ing foot­print. The Chica­go-based phar­ma is spend­ing $223 mil­lion to ex­tend its on­ly man­u­fac­tur­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER